GBS is a researched based pharmaceutical company , offer development services to the pharma, agro and biotech industries and at the same time creating long –term value through internal and collaborative innovative Drug Discovery.
GBS is privately owned contract research organization (CRO) which is supporting pharmaceuticals and biotechnology companies by providing quality and cost effective preclinical services and laboratory animals.
Our work ethics are built on a customer – centric science foundation. The multitude of scientific disciplines provides a platform for an integrated learning experience in the challenging world of drug discovery.
GBS business model is focused on creating a profitable, sustainable business through a mix of partnering (collaborative Drug Discovery), early – stage Licensing and services models. Different business models including various shades of risk-sharing, with flexible win-win relationship help both GBS and its partners create value for the long term.
We are committed to quality, confidentiality and ethics in our services that exceed the expectations and continue to improve the systems and processes through innovations.
We stand for 4R-refinement, reduction, replacement and rehabilitation in animal experimentatione.